22nd Annual International Ultmann Chicago Lymphoma Symposium

Chicago, IL US
April 4, 2025 to April 5, 2025
The 22nd International Ultmann Chicago Lymphoma Symposium (IUCLS) is a continuation of an annual conference dedicated solely to the science and clinical care of lymphoma. It has been organized to honor the achievements of Dr. John Ultmann, a pioneer in the treatment of lymphoma, who devoted his life to the understanding of this disease. He was particularly known for his work on the staging of Hodgkin lymphoma and the utility of staging as a guide for treatment.

The goal of this educational activity is to facilitate a forum for physicians, nurses, researchers, and other healthcare professionals to discuss biologic, diagnostic, and therapeutic aspects of Hodgkin and non-Hodgkin lymphoma.

This event gives opportunities for providers to explore vital information on clinical updates and research in order to ensure they are using the latest treatment options in their practice.
 
Learn more at the symposium website!
                                          
 

Target Audience

The target audience for this symposium is practicing oncologists, hematologists, advanced nurse practitioners, physician assistants, residents, fellows, nurses, pharmacists, and the other health professionals interested in the treatment and diagnosis of lymphoma.

Learning Objectives

At the conclusion of this educational activity, participants will be able to:

  • Assess clinical trial results of approved and investigational treatment strategies being studied in patients with indolent and aggressive subtypes of B-cell and T-cell non-Hodgkin lymphoma
  • Compare and contrast the selection and sequencing of therapeutic approaches for the care of patients with newly diagnosed and relapsed/refractory Hodgkin lymphoma
  • Evaluate the various patient and disease-related factors that may impact therapeutic decisions for patients with newly diagnosed and previously treated CLL/SLL
  • Review approaches to the care of patients with rarer hematologic malignancies, including CNS lymphoma and Waldenstrom macroglobulinemia
  • Identify and nurture strategies to enhance communication and collaboration with the entire multidisciplinary healthcare team during the continuum of care of patients with lymphoma
Additional information
ACGME/ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Interpersonal and Communication Skills
For more information, please contact:
CME Coordinator Contact Name: 
Conference Secretariat
CME Coordinator Contact Email: 
Summary
Available credit: 
  • 14.50 ABIM Medical Knowledge
  • 14.50 AMA PRA Category 1 Credit™
  • 14.50 Nursing Contact Hours
  • 14.50 Participation
Event starts: 
04/04/2025 - 8:00am
Event ends: 
04/05/2025 - 4:35pm
Activity opens: 
04/04/2025
Activity expires: 
07/04/2025
Westin Chicago River North
320 N Dearborn St
Chicago, IL 60654
United States
WANT TO KNOW MORE?
Learn more about the program by visiting the symposium website! For questions, contact the Conference Secretariat via e-mail.
 
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office via e-mail at iucls@bioascend.com.
 
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
SYMPOSIUM CO-CHAIRS
  Sonali M. Smith, MD
  Elwood V. Jensen Professor of Medicine
  Chief, Section of Hematology/Oncology
  Director, Lymphoma Program
  The University of Chicago
 
 
  Andrew M. Evens, DO, MBA, MSc
  Professor of Medicine, Rutgers Robert Wood Johnson Medical School 
  Associate Director for Clinical Services, Rutger Cancer Institute of New Jersey
  Director, Lymphoma Program, Division of Blood Disorders 
  Medical Director, Oncology Service Line, RWJBarnabas Health
 
 
  Timothy S. Fenske, MD
  Professor, Division of Hematology and Oncology
  Medical College of Wisconsin
  Milwaukee, Wisconsin
 
 
 
  Neha Mehta-Shah, MD, MSCI
  Assistant Professor of Medicine
  Washington University of St. Louis

 

 

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and Bio Ascend LLC. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 14.50 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit
University of Chicago Medicine is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
 
This live activity is designated for a maximum of 14.5 continuing nursing education units.
 
American Board of Internal Medicine MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 14.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Other Health Professional Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credits from organizations accredited by the ACCME, please consult your professional licensing board.

Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.
REGISTRATION: Click the button below for complete registration information and to register. Early-bird rates are available through March 4, 2025. For questions or concerns, please contact the Conference Secretariat via e-mail.


Symposium and Interprofessional Session

 Profession Type  
Early Bird Fee
After Early Bird Fee 
Physician/PharmD/PhD$350$400
Nurse/OHP$175$200
Fellow/Resident/Student$150$200
Pharma Industry/Representative
(Non-Exhibitor)
$625$775
 
Symposium ONLY
 
Profession TypeEarly Bird FeeAfter Early Bird Fee
Physician/PharmD/PhD$300$350
Nurse/OHP$150$200
Fellow/Resident/Student$125$150
Pharma Industry/Representative
(Non-Exhibitor)
$475$525
 
Interprofessional Session ONLY
 
Profession TypeEarly Bird FeeAfter Early Bird Fee
Physician/PharmD/PhD$125$175
Nurse/OHP$100$125
Fellow/Resident/Student$100$125
Pharma Industry/Representative
(Non-Exhibitor)
$175$225
 

CANCELLATION POLICY:  See website for complete information.

 
 
 
 

 
CLAIMING CREDIT: After the conference, create an account or log in and enter the access code to unlock the credit claiming process.
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.
 
Please login or create an account to proceed.